AI assistant
Sending…
Co-Diagnostics, Inc. — Director's Dealing 2020
Jun 4, 2020
35011_dirs_2020-06-04_639fbd60-a0bd-4be0-a30c-bc15d78b17e8.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Co-Diagnostics, Inc. (CODX)
CIK: 0001692415
Period of Report: 2019-06-25
Reporting Person: Durenard Eugene (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2019-06-25 | Non-Qualified Stock Option (right to buy) | $0.71 | A | 25000 | Acquired | 2029-06-24 | Common Stock (25000) | Direct |
| 2020-02-10 | Non-Qualified Stock Option (right to buy) | $3.96 | A | 25000 | Acquired | 2030-02-09 | Common Stock (25000) | Direct |
More from Co-Diagnostics, Inc.
Capital/Financing Update
2026
May 28
Capital/Financing Update
2026
May 21
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
May 14
Major Shareholding Notification
2026
Feb 11
Regulatory Filings
2026
Jan 21
Delisting Announcement
2026
Jan 13
Share Issue/Capital Change
2025
Dec 30
Capital/Financing Update
2025
Dec 19
Declaration of Voting Results & Voting Rights Announcements
2025
Dec 5